The role of hypoxia-inducible factors in tumorigenesis

Rankin, E B, Giaccia, A J·2008·Cell Death & Differentiation

Cited by (808)

Items 401–500 of 808

  1. SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets
    Stefania Cannito, Beatrice Foglia, Gianmarco Villano, Cristian Turato, Teresa C. Delgado, Elisabetta Morello, Fabrizio Pin, Erica Novo, Lucia Napione, Santina Quarta et al. · 2019 · Cancers
  2. Boron in cancer therapeutics: An overview
    Swanand Kulkarni, Dyuti Bhandary, Yogesh Singh, Vikramdeep Monga, Suresh Thareja · 2023 · Pharmacology & Therapeutics
  3. Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration
    Annelies Quaegebeur, Peter Carmeliet · 2010 · Current topics in microbiology and immunology
  4. siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells
    Xian‐Yang Qin, Feifei Wei, Jun Yoshinaga, Junzo Yonemoto, Masaru Tanokura, Hideko Sone · 2011 · FEBS Letters
  5. A mathematical model of HiF-1-mediated response to hypoxia on the G1/S transition
    Baptiste Bedessem, A. Stéphanou · 2013 · Mathematical Biosciences
  6. Hypoxia-inducible factor-1: A possible link between inhalational anesthetics and tumor progression?
    Hailin Zhao, Masae Iwasaki, Jiali Yang, Sinead Savage, Daqing Ma · 2014 · Acta anaesthesiologica Taiwanica
  7. Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells
    Hongyan Zhao, Dali Zhao, Huilin Jin, Hongwei Li, Xiaoying Yang, Liwei Zhuang, Tiefu Liu · 2016 · Molecular Medicine Reports
  8. Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
    Sakshi Taneja, Stefan W. Vetter, Estelle Leclerc · 2021 · International Journal of Molecular Sciences
  9. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT
    Lifang Shen, Xin Zhao, Shui‐Hong Zhou, Zhongjie Lu, Kui Zhao, Jun Fan, Min-Li Zhou · 2017 · Oncotarget
  10. Biological aspects of angiogenesis in multiple myeloma
    Eléonore Otjacques, Marilène Binsfeld, Agnès Noël, Yves P. Beguin, Didier D Cataldo, Jo Caers · 2011 · International Journal of Hematology
  11. Effects of Lipoxin A4 on CoCl2-Induced Angiogenesis and Its Possible Mechanisms in Human Umbilical Vein Endothelial Cells
    Song-Jun Liu, Ping Wu, Duyun Ye, Yinping Huang, Xiaoyan Zhou, Yongsheng Li, Lei Cai · 2009 · Pharmacology
  12. Osteopontin Upregulates the Expression of Glucose Transporters in Osteosarcoma Cells
    I‐Shan Hsieh, Rong‐Sen Yang, Wen Fu · 2014 · PLoS ONE
  13. Physiological Targeting to Improve Anticancer Drug Selectivity
    Trevor W. Hambley · 2008 · Australian Journal of Chemistry
  14. Hypoxia-inducible factor: roles in development, physiology, and disease
    Chandel, N S, Simon, M C · 2008 · Cell Death & Differentiation
  15. 2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma
    Han Lin, Xian Li Jiang, Huaqiang Zhu, Wenjing Jiang, Xuesong Dong, Haiquan Qiao, Xueying Sun, Hongchi Jiang · 2015 · Tumor Biology
  16. On the relationship between VDR, RORα and RORγ receptors expression and HIF1‐α levels in human melanomas
    Anna A. Brożyna, Wojciech Jóźwicki, Anton M. Jetten, Andrzej T. Slominski · 2019 · Experimental Dermatology
  17. Tumor suppressor WWOX moderates the mitochondrial respiratory complex
    Amanda Choo, Louise V. O’Keefe, Cheng Shoou Lee, Stephen L. Gregory, Zeeshan Shaukat, Alexander D. Colella, Kristie Lee, Donna Denton, Robert I. Richards · 2015 · Genes Chromosomes and Cancer
  18. Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway
    Pinelopi Argyriou, Sotirios G. Papageorgiou, Varvara Panteleon, Amanda K. Psyrri, Vassiliki Bakou, Vasiliki Pappa, Aris Spathis, Panagiota Economopoulou, E. S. Papageorgiou, Theofanis Economopoulos et al. · 2010 · Annals of Hematology
  19. Prognostic Role of Hypoxic Inducible Factor Expression in Non-small Cell Lung Cancer: A Meta-analysis
    Cong Li, Hua-Jun Lu, Feifei Na, Lei Deng, Jianxin Xue, Jingwen Wang, Yuqing Wang, Qiaoling Li, You Lü · 2013 · Asian Pacific Journal of Cancer Prevention
  20. Distribution of Hypoxia-Inducible Factor-1α and Glucose Transporter-1 in Human Tongue Cancers
    Marcelo Gadelha Vasconcelos, Rodrigo Gadelha VASCONCELOS, Denise Hélen Imaculada Pereira de Oliveira, Edilmar de Moura Santos, Leão Pereira Pinto, Éricka Janine Dantas da Silveira, Lélia María Guedes Queiroz · 2015 · Journal of Oral and Maxillofacial Surgery
  21. Polyphyllin D Exerts Potent Anti-tumour Effects on Lewis Cancer Cells under Hypoxic Conditions
    D-D Ma, H-X Lu, L-S Xu, Wei Lie Xiao · 2009 · Journal of International Medical Research
  22. Association between FBP1 and hypoxia-related gene expression in clear cell renal cell carcinoma
    Xianghui Ning, Li Teng, Yanqing Gong, Qun He, QI SHEN, Shuanghe Peng, Jiangyi Wang, JIN-CHAO CHEN, Yinglu Guo, Kan Gong · 2016 · Oncology Letters
  23. Inhibition of histone/lysine acetyltransferase activity kills CoCl2-treated and hypoxia-exposed gastric cancer cells and reduces their invasiveness
    Suvasmita Rath, Lopamudra Das, Shrikant Babanrao Kokate, Nilabh Ghosh, Pragyesh Dixit, Niranjan Rout, Shivaram Prasad Singh, Subhasis Chattopadhyay, Hassan Ashktorab, Duane T. Smoot et al. · 2016 · The International Journal of Biochemistry & Cell Biology
  24. The Transcription Factor Hif-1 Enhances the Radio-Resistance of Mouse MSCs
    Irene Calvo‐Asensio, Eugène Dillon, Noel Francis Lowndes, Rhodri Ceredig · 2018 · Frontiers in Physiology
  25. The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor
    Dan Zhang, Hexia Xia, Wei Zhang, Bo Fang · 2015 · Tumor Biology
  26. Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor Growth
    Jonathan M. Harnoss, Lisa Katharina Platzer, Jürgen Burhenne, Praveen Radhakrishnan, Jun Cai, Moritz J. Strowitzki, Johanna Weiß, Alina S. Ritter, Martin Mollenhauer, Thomas Schmidt et al. · 2016 · Annals of Surgery
  27. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis
    Susu Han, Tao Huang, Wen Li, Shanshan Liu, Wei Yang, Qi Shi, Hongjia Li, Jianlin Ren, Fenggang Hou · 2018 · Cellular Physiology and Biochemistry
  28. The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells
    Boren Tian, Xiaoyun Du, Shiyu Zheng, Yan Zhang · 2022 · International Journal of Molecular Sciences
  29. Angiomodulatory properties of Rhodiola spp. and other natural antioxidants
    Dorota Magdalena Radomska-Leśniewska, Piotr Skopiński, Barbara Joanna Bałan, Agata Białoszewska, Jarosław Jóźwiak, Dariusz Rokicki, Ewa Skopińska-Różewska, Anna Borecka, Agata Hevelke · 2015 · Central European Journal of Immunology
  30. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review
    Yuxuan Wei, Lei Wang, Jin Zheng, Qingzhu Jia, Luka Brčić, Tomohiro Akaba, Qian Chu · 2024 · Translational Lung Cancer Research
  31. A fluorescent nanoprobe based on azoreductase-responsive metal–organic frameworks for imaging VEGF mRNA under hypoxic conditions
    Na Liu, Zhen Zou, Jin Liu, Cong Zhu, Jing Zheng, Ronghua Yang · 2019 · The Analyst
  32. Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors
    Reinier Alvarez, Debjani Mandal, Prashant Chittiboina · 2021 · Cells
  33. E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation
    Sun-Bin Ling, Qi-Fan Zhan, Guang-Jiang Jiang, Qiaonan Shan, Lu Yin, Rui Wang, Qingyang Que, Xu-Yong Wei, Sheng-Jun Xu, Jiong-Jie Yu et al. · 2022 · American Journal of Transplantation
  34. Inducing vascular normalization: A promising strategy for immunotherapy
    Xin Luo, Wei Zou, Zhonghong Wei, Suyun Yu, Yang Zhao, Yuanyuan Wu, Aiyun Wang, Yin Lu · 2022 · International Immunopharmacology
  35. The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma
    Josipa Kokeza, Ante Strikić, Marin Ogorevc, Nela Kelam, Martina Vukoja, Ivo Dilber, Sandra Zekić Tomaš · 2023 · International Journal of Molecular Sciences
  36. ETV2 (Ets Variant Transcription Factor 2)- Rhoj Cascade Regulates Endothelial Progenitor Cell Migration During Embryogenesis
    Bhairab N. Singh, Javier E. Sierra-Pagán, Wuming Gong, Satyabrata Das, Joshua W. M. Theisen, Erik Skie, Mary G. Garry, Daniel J. Garry · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
  37. Microarray analyses of hypoxia‐regulated genes in an aryl hydrocarbon receptor nuclear translocator (Arnt)‐dependent manner
    Su‐Mi Choi, Hookeun Oh, Hyunsung Park · 2008 · FEBS Journal
  38. Potent 19-Norvitamin D Analogs For Prostate And Liver Cancer Therapy
    Atsushi Kittaka, Akihiko Yoshida, Kun‐Chun Chiang, Masashi Takano, Daisuke Sawada, Toshiyuki Sakaki, Tai C. Chen · 2012 · Future Medicinal Chemistry
  39. Bifurcated BACH2 control coordinates mantle cell lymphoma survival and dispersal during hypoxia
    Han Zhang, Zheng Chen, Roberto N. Miranda, Leonard Jeffrey Medeiros, Nami McCarty · 2017 · Blood
  40. Paradoxical Regulation of Hypoxia Inducible Factor-1α (HIF-1α) by Histone Deacetylase Inhibitor in Diffuse Large B-Cell Lymphoma
    Savita Bhalla, Andrew M. Evens, Sheila Prachand, Paul T. Schumacker, Leo I. Gordon · 2013 · PLoS ONE
  41. The relationship between the preoperative plasma level of HIF-1α and clinic pathological features, prognosis in non-small cell lung cancer
    Jiabei He, Ying Hu, Ming‐Ming Hu, Siyi Zhang, Baolan Li · 2016 · Scientific Reports
  42. Ischemia Is Related to Tumour Genetics in Uveal Melanoma
    Niels J. Brouwer, Annemijn P. A. Wierenga, Gülçin Gezgin, Marina Marinkovic, Gregorius P. M. Luyten, Wilma G. M. Kroes, Mieke Versluis, Pieter A. van der Velden, Robert M. Verdijk, Martine Johanna Jager · 2019 · Cancers
  43. Metabolic Potential of Cancer Cells in Context of the Metastatic Cascade
    Mohaned Benzarti, Catherine Delbrouck, Laura Neises, Nicole Kiweler, Johannes Meiser · 2020 · Cells
  44. Combinatorial Control of Transgene Expression by Hypoxia-Responsive Promoter and MicroRNA Regulation for Neural Stem Cell-Based Cancer Therapy
    Yumei Luo, Detu Zhu · 2014 · BioMed Research International
  45. Integration and Visualization of Regulatory Elements and Variations of the EPAS1 Gene in Human
    Aleša Kristan, Nataša Debeljak, Tanja Kunej · 2021 · Genes
  46. Programming DNA Nanoassembly for Enhanced Photodynamic Therapy
    Min Pan, Qunying Jiang, Junlin Sun, Zhen Xu, Yizhuo Zhou, Li Zhang, Xiaoqing Liu · 2019 · Angewandte Chemie
  47. Complex role of HIF in cancer: the known, the unknown, and the unexpected
    Eric L. Huang, Patricia D.B. Tiburcio, Hyunsung Choi · 2014 · Hypoxia
  48. Hypoxia-inducible factor-1α regulates the expression of L-type voltage-dependent Ca2+ channels in PC12 cells under hypoxia
    Ran Li, Yong Wang, Zhaofei Yang, Yun‐Ling He, Tong Zhao, Ming Fan, Xuan Wang, L C Zhu, Xiaomin Wang · 2015 · Cell Stress and Chaperones
  49. ASPS-1, A Novel Cell Line Manifesting Key Features of Alveolar Soft Part Sarcoma
    Susan Kenney, David Thomas Vistica, Luke H. Stockwin, Sandra Sczerba Burkett, Melinda G. Hollingshead, Suzanne D. Borgel, Donna O. Butcher, David S. Schrump, Robert H. Shoemaker · 2011 · Journal of Pediatric Hematology/Oncology
  50. Mutational analysis of hypoxia‐related genes HIF1α and CUL2 in common human cancers
    Sang Wook Park, Nak Gyun Chung, Soo Young Hur, Ho Shik Kim, Nam Jin Yoo, Sug Hyung Lee · 2009 · Apmis
  51. Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1α-mediated mechanism
    Guo-Ting Pei, Chi-Wei Wu, Wan‐Wan Lin · 2009 · Biochemical and Biophysical Research Communications
  52. Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer
    Abderrahim El Guerrab, Anne Cayre, Fabrice Kwiatkowski, Maud Privat, Jean-Marc Rossignol, Fabrice Rossignol, Frederique Madeleine Penault-Llorca, Yves‐Jean Bignon · 2017 · PLoS ONE
  53. TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect
    Yutong Xing, Peng Luo, Rui Hu, Duanduan Wang, Gang Zhou, Jie Jiang · 2020 · Cancer Management and Research
  54. GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors
    John M. Ryniawec, Matthew R. Coope, Emily Loertscher, Vignesh Bageerathan, Diogo de Oliveira Pessôa, Noel A. Warfel, Anne E. Cress, Megha Padi, Gregory C. Rogers · 2022 · Diagnostics
  55. Effect of Curcumin on Attenuation of Liver Cirrhosis via Genes/Proteins and Pathways: A System Pharmacology Study
    Ali Asghar Mahmoudi, Stephen Lawrence Atkin, Tannaz Jamialahmadi, Maciej Banach, Amirhossein Sahebkar · 2022 · Nutrients
  56. Forces at play: exploring factors affecting the cancer metastasis
    Farooq Riaz, Jing Zhang, Fan Pan · 2024 · Frontiers in Immunology
  57. Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase
    Sunny Guin, Qi Ma, Snehal Padhye, Yong-Qing Zhou, Hangping Yao, Ming‐Hai Wang · 2010 · Cancer Chemotherapy and Pharmacology
  58. Enhanced expression of melanoma progression markers in mouse model of sleep apnea
    Sílvio César Perini, Dênis Martinez, Carolina Caruccio Montanari, Cintia Zappe Fiori · 2016 · Revista Portuguesa de Pneumologia
  59. Role, Targets and Regulation of (de)nitrosylation in Malignancy
    Salvatore Rizza, Giuseppe Filomeni · 2018 · Frontiers in Oncology
  60. Tumor regression and potentiation of polymeric vascular disrupting therapy through reprogramming of a hypoxia microenvironment with temsirolimus
    Haiyang Yu, Na Shen, Yanli Bao, Li Chen, Zhaohui Tang · 2019 · Biomaterials Science
  61. The Roles of Hypoxia-Inducible Factors and Non-Coding RNAs in Gastrointestinal Cancer
    Hyun‐Soo Cho, Tae‐Su Han, Keun Hur, Hyun Seung Ban · 2019 · Genes
  62. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup
    Yajuan J. Liu, Jane Houldsworth, Rajyasree Emmadi, Lisa M. Dyer, Daynna J. Wolff · 2020 · Cancer Genetics
  63. Heparanase from triple‑negative breast cancer and platelets acts as an enhancer of metastasis
    Wenjing Yang, Gan‑Lin Zhang, Kexin Cao, Xiao‐Ni Liu, Xiaomin Wang, Mingwei Yu, Jin-Ping Li, Guowang Yang · 2020 · International Journal of Oncology
  64. Boosting Nanomedicine Efficacy with Hyperbaric Oxygen Therapy
    Xiaoxian Wang, Si Li, Xin Liu, Xian Guo Wu, Ningbing Ye, Xiangliang Yang, Zifu Li · 2021 · Advances in experimental medicine and biology
  65. Betacellulin inhibits osteogenic differentiation and stimulates proliferation through HIF-1α
    Damian C. Genetos, Rameshwar R. Rao, Martin A. Vidal · 2010 · Cell and Tissue Research
  66. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo
    Sonia Levi · 2010 · International Journal of Oncology
  67. Expression of nerve growth factor and hypoxia inducible factor-1α and its correlation with angiogenesis in non-small cell lung cancer
    Qingli Lu, Jian Liu, Xiaoli Zhu, Wenjia Xu · 2014 · Journal of Huazhong University of Science and Technology [Medical Sciences]
  68. FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
    Martin Doležel, M Slavík, Tomáš Blažek, Tomáš Kazda, Pavel Koranda, Lucia Veverková, Petr Burkoň, Jakub Cvek · 2022 · Journal of Personalized Medicine
  69. Regulation of Metastasis in Ewing Sarcoma
    Mingli Li, Chun-Wei David Chen · 2022 · Cancers
  70. Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney disease
    Haase, Volker H., Tanaka, Tetsuhiro, Koury, Mark J. · 2024 · Hematology
  71. Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development
    Mu-Tai Liu, Mu-Kuan Chen, Chia-Chun Huang, Chao‐Yuan Huang · 2015 · World Journal of Oncology
  72. Hypoxia-related gene expression profile in childhood acute lymphoblastic leukemia: prognostic implications
    Vanessa S. Silveira, Bruno Marcelo Rocha Freire, Kleiton Silva Borges, Augusto Faria Andrade, Gustavo Alencastro Veiga Cruzeiro, João Paulo J. Sabino, Mogens Lesner Glass, José Andrés Yunes, Sílvia Regina Brandalise, Luíz Gonzaga Tone et al. · 2013 · Leukemia & lymphoma/Leukemia and lymphoma
  73. The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment
    Markus Mandl, Maria- Katharina Lieberum, Juergen Dunst, Reinhard Depping · 2015 · Radiation Oncology
  74. Prolyl Hydroxylase 3 Attenuates MCL-1–Mediated ATP Production to Suppress the Metastatic Potential of Colorectal Cancer Cells
    Praveenkumar Radhakrishnan, Nadine Ruh, Jonathan M. Harnoss, Judit Kiss, Martin Mollenhauer, Anna‐Lena Scherr, Lisa Katharina Platzer, Thomas Schmidt, Klaus Podar, Joseph T. Opferman et al. · 2016 · Cancer Research
  75. E2F3 upregulation promotes tumor malignancy through the transcriptional activation of HIF-2α in clear cell renal cell carcinoma
    Yu Gao, Hongzhao Li, Xin Ma, Fan Yang, Dong Ni, Yu Zhang, Qingbo Huang, Kan Liu, Xintao Li, Lei Wang et al. · 2016 · Oncotarget
  76. The prognosis outcome of oral squamous cell carcinoma using HIF-2α
    Elva Lim, Chia‐Chun Kuo, Hsi‐Feng Tu, Cheng‐Chieh Yang · 2017 · Journal of the Chinese Medical Association
  77. Thioredoxin overexpression in both the cytosol and mitochondria accelerates age-related disease and shortens lifespan in male C57BL/6 mice
    Geneva M. Cunningham, Lisa C. Flores, Madeline G. Roman, Christie Cheng, Sara Dube, Colton Allen, Joseph M. Valentine, Gene B. Hubbard, Yidong Bai, Thomas L. Saunders et al. · 2018 · GeroScience
  78. Functional changes in murine mammary cancer cells elicited by CoCl2-induced hypoxia
    Ximena Borenstein, Gabriel L. Fiszman, Ada Gabriela Blidner, Silvia Inés Vanzulli, Maria Adela Jasnis · 2010 · Nitric Oxide
  79. Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
    Taymin du Toit‐Thompson, Lionel Yi Wen Leck, Josef Gillson, Nick Pavlakis, Anthony James Gill, Jaswinder Singh Samra, Anubhav Mittal, Sumit Sahni · 2025 · Advanced Drug Delivery Reviews
  80. Metabolomics of Glioma
    Sizhe Feng, Yutong Liu · 2021 · Advances in experimental medicine and biology
  81. The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment
    Pengcheng Sun, Xiao Wei Zheng, Xiaodong Li · 2022 · Journal of Oncology
  82. “Pulsed Hypoxia” Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal–Epithelial Transition
    Anna A. Nushtaeva, Mikhail S. Ermakov, Maria Abdurakhmanova, Olga S. Troitskaya, Беловежец Татьяна Николаевна, Mikhail Varlamov, Tatyana A. Gayner, Vladimir Alexandrovich Richter, Olga A. Koval · 2023 · International Journal of Molecular Sciences
  83. The pro-migratory and pro-invasive role of the procoagulant tissue factor in malignant gliomas
    Stephan Duetzmann, Florian A Gessler, Patrick N. Harter, Rüdiger Gerlach, Michel Guy André Mittelbronn, Volker Seifert, Donat Kögel · 2010 · Cell Adhesion & Migration
  84. Characterization of the hypoxia-inducible factor 1 alpha gene in the sperm whale, beluga whale, and Yangtze finless porpoise
    Jianling Bi, Bo Hu, Jinsong Zheng, Jingzhen Wang, Wuhan Xiao, Ding Wang · 2015 · Marine Biology
  85. Histone methylation regulates Hif‐1 signaling cascade in activation of hepatic stellate cells
    Fei Hong, Lu Wan, Jie Liu, Ke Huang, Zhenmeng Xiao, Yingjing Zhang, Chunwei Shi · 2018 · FEBS Open Bio
  86. Expression and association of carbonic anhydrase IX and cyclooxygenase-2 in colorectal cancer
    Veronika Tupá, Slávka Drahošová, Marián Grendár, Marián Adamkov · 2019 · Pathology - Research and Practice
  87. Value of HIF-1α as an independent prognostic indicator in oral squamous cell carcinoma
    Wanninayake Mudiyanselage Tilakaratne, Eranga H. Nissanka-Jayasuriya · 2011 · Expert Review of Molecular Diagnostics
  88. VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin
    Michelle J. Nyhan, Shereen M. El Mashad, Tracey R. O’Donovan, Sarfraz Ahmad, Chris G. Collins, Paul Sweeney, Eamonn Rogers, Gerald C. O’Sullivan, Sharon L. McKenna · 2011 · Cellular Oncology
  89. Delivery of siRNA targeting HIF-1α loaded chitosan modified d -α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin
    Daizheng Lian, Yuhan Chen, Gang Xu, Xiaowei Zeng, Zhuangling Li, Zihuang Li, Yayan Zhou, Lin Mei, Xianming Li · 2016 · RSC Advances
  90. Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer
    C-S Lu, J-L Hsieh, C-Y Lin, H-W Tsai, B-H Su, G-S. Shieh, Y-C Su, C-H Lee, M-Y Chang, Chao‐Liang Wu et al. · 2015 · Gene Therapy
  91. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma therapy
    Xianming Li, Yuhan Chen, Gang Xu, Yi Zheng, Maosheng Yan, Zihuang Li, Yayan Zhou, Lin Mei · 2015 · International Journal of Nanomedicine
  92. Cellular overexpression of Aquaporins slows down the natural HIF-2α degradation during prolonged hypoxia
    Ana Galán‐Cobo, Rocı́o Sánchez-Silva, Ana Serna‐Gallego, Irene Abreu‐Rodríguez, Ana María Muñoz-Cabello, Miriam Echevarrı́a · 2013 · Gene
  93. Distinct APE1 Activities Affect the Regulation of VEGF Transcription Under Hypoxic Conditions
    Mengxia Li, Nan Dai, Dong Wang, Zhaoyang Zhong · 2019 · Computational and Structural Biotechnology Journal
  94. Subcellular distribution of S100A4 and its transcriptional regulation under hypoxic conditions in gastric cancer cell line BGC823
    Ruixiu Zhang, Hao Fu, Danqi Chen, Jun Hua, Yanping Hu, Kailai Sun, Xiuju Sun · 2010 · Cancer Science
  95. ELL is an HIF‐1α partner that regulates and responds to hypoxia response in PC3 cells
    Lingqi Liu, Junkui Ai, Wuhan Xiao, June Liu, Yujuan Wang, Dianqi Xin, Zhisong He, Yinglu Guo, Zhou Wang · 2010 · The Prostate
  96. Sirtuins and Hypoxia in EMT Control
    Michele Aventaggiato, Federica Barreca, Luigi Sansone, Laura Pellegrini, Matteo Antonio Russo, Marco Cordani, Marco Tafani · 2022 · Pharmaceuticals
  97. The angiogenic role of the alpha 9-nicotinic acetylcholine receptor in triple-negative breast cancers
    Sonjid Ochirbat, Tzu-Chun Kan, Chun‐Chun Hsu, Tzu-Hsuan Huang, Kuo-Hsiang Chuang, Michael J. Chen, Chun‐Chia Cheng, Chun‐Chao Chang, Sri Rahayu, Jungshan Chang · 2024 · Angiogenesis
  98. Emerging drugs in the treatment of pancreatic cancer
    Devalingam Mahalingam, Kevin R. Kelly, Ronan T. Swords, Jennifer S. Carew, Steffan T. Nawrocki, Francis Joseph Giles · 2009 · Expert Opinion on Emerging Drugs
  99. Perioperative Treatment with a Prolyl Hydroxylase Inhibitor Reduces Necrosis in a Rat Ischemic Skin Flap Model
    Amanda R. Sergesketter, Roger W. Cason, Mohamed M. Ibrahim, Whitney O. Lane, David T. Lubkin, Scott Thomas Hollenbeck, David A. Brown · 2019 · Plastic & Reconstructive Surgery
  100. Caveolin-1-Mediated Tumor Suppression Is Linked to Reduced HIF1α S-Nitrosylation and Transcriptional Activity in Hypoxia
    Carlos Sanhueza, Jimena Castillo Bennett, Manuel Valenzuela, Pamela Contreras, Lorena Lobos‐González, America V. Campos, Sergio Wehinger, Álvaro Lladser, Rolf W. Kiessling, Lisette Leyton et al. · 2020 · Cancers